Cargando…

ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis

MicroRNAs (miRNAs), which are endogenous short noncoding RNAs, can regulate genes involved in important biological and pathological functions. Therefore, dysregulation of miRNAs plays a critical role in cancer progression. However, whether the aberrant expression of miRNAs is regulated by oncogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Kuo-Liang, Lin, Yu-Sen, Kuo, Ting-Ting, Lo, Chia-Chien, Huang, Yu-Kai, Chang, Hsien-Fang, Chuang, Eric Y., Lin, Ching-Chan, Cheng, Wei-Chung, Liu, Yen-Nien, Lai, Liang-Chuan, Sher, Yuh-Pyng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564571/ https://www.ncbi.nlm.nih.gov/pubmed/28537886 http://dx.doi.org/10.18632/oncotarget.17648

Ejemplares similares

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023)

An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020)

ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
por: Sher, Yuh-Pyng, et al.
Publicado: (2014)

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
por: Lin, Yu-Sen, et al.
Publicado: (2021)

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017)

The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma
por: Geng, Fei, et al.
Publicado: (2020)

Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
por: Lin, Ching-Chan, et al.
Publicado: (2020)

Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
por: Lai, Liang-Chuan, et al.
Publicado: (2011)

Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells
por: Li, En-Yu, et al.
Publicado: (2016)

Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
por: Yang, Lifang, et al.
Publicado: (2015)

CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma
por: Liu, Chien-Liang, et al.
Publicado: (2023)

MicroRNA-769-3p Down-regulates NDRG1 and Enhances Apoptosis in MCF-7 Cells During Reoxygenation
por: Luo, En-Ching, et al.
Publicado: (2014)

New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways
por: He, Yaowu, et al.
Publicado: (2016)

CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells
por: Orchard-Webb, David J, et al.
Publicado: (2014)

CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis
por: Zhang, Lingjun, et al.
Publicado: (2022)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
por: Harrington, Brittney S., et al.
Publicado: (2020)

Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis
por: Karachaliou, Niki, et al.
Publicado: (2018)

CDCP1 promotes compensatory renal growth by integrating Src and Met signaling
por: Kajiwara, Kentaro, et al.
Publicado: (2021)

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
por: Cuda, Tahleesa J., et al.
Publicado: (2021)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells
por: Ko, Pin-Hao, et al.
Publicado: (2019)

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
por: Cheng, Wei-Chung, et al.
Publicado: (2021)

ADAM metalloproteases and EGFR signalling
por: Gee, Julia MW, et al.
Publicado: (2003)

Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
por: Liu, Chien-Ming, et al.
Publicado: (2015)

Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[(18)F]-ADAM PET Imaging
por: Tsai, Chi-Jung, et al.
Publicado: (2022)

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020)

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)

Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2012)

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
por: Jia, Xi, et al.
Publicado: (2023)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
por: Turdo, Federica, et al.
Publicado: (2016)

Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease
por: Blanco, Jose-Ramon, et al.
Publicado: (2022)

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer
por: Zhao, Jinlu, et al.
Publicado: (2022)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein
por: Urabe, Fumihiko, et al.
Publicado: (2023)

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
por: Forte, Luca, et al.
Publicado: (2018)

Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases
por: Magnusson, Louise, et al.
Publicado: (2020)

Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
por: Lim, Shion A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c9fhr40gt4jgl94hobdma82q1o